Parkash, Vivak http://orcid.org/0000-0001-9701-5767
Ashwin, Helen http://orcid.org/0000-0003-1029-0032
Dey, Shoumit http://orcid.org/0000-0003-2655-9921
Sadlova, Jovana http://orcid.org/0000-0002-0432-2707
Vojtkova, Barbora
Van Bocxlaer, Katrien
Wiggins, Rebecca
Thompson, David
Dey, Nidhi Sharma http://orcid.org/0000-0001-9432-0221
Jaffe, Charles L.
Schwartz, Eli
Volf, Petr http://orcid.org/0000-0003-1790-1123
Lacey, Charles J. N.
Layton, Alison M. http://orcid.org/0000-0003-0473-3319
Kaye, Paul M. http://orcid.org/0000-0002-8796-4755
Funding for this research was provided by:
RCUK | Medical Research Council (MR/R014973, MR/R014973, MR/R014973, MR/R014973, MR/R014973, MR/R014973, MR/R014973, MR/R014973, MR/R014973, MR/R014973, MR/R014973, MR/R014973, MR/R014973, MR/R014973, MR/R014973)
EC | European Regional Development Fund (CePaViP 16_019/0000759, CePaViP 16_019/0000759, CePaViP 16_019/0000759, CePaViP 16_019/0000759)
Article History
Received: 18 October 2023
Accepted: 20 June 2024
First Online: 2 August 2024
Competing interests
: P.M.K. and C.J.N.L. are co-authors of a patent protecting the gene insert used in <i>Leishmania</i> candidate vaccine ChAd63-KH (Europe 10719953.1; India 315101). The other authors declare no competing interests.